Autres langues Veloxis Pharmaceuticals A/S

Actions

VELO

DK0060048148

Produits pharmaceutiques

Temps Différé Nasdaq Copenhagen			Varia. 5j.	Varia. 1 janv.
- ^DKK	-.--%		-.--%	-0,50%

30/05/24	Veloxis Pharmaceuticals A/S choisit de présenter ses travaux au 2024 American Transplant Congress à Philadelphie	CI
28/06/22	Veloxis Pharmaceuticals annonce le dosage du premier patient par son partenaire Xenikos dans l'étude mondiale de phase 3 évaluant T-Guard(R) chez les patients atteints de la maladie aiguë du greffon contre l'hôte réfractaire aux stéroïdes (SR-aGVHD)	CI

Autres langues

30/05/24	Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia
28/06/22	Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
02/06/21	Scandion Oncology A/S : appoints Johnny Stilou as new CFO
26/04/21	Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
17/02/20	Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
17/02/20	Veloxis Pharmaceuticals A/S Announces Board Appointments
07/02/20	Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
30/01/20	Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
30/01/20	Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
29/01/20	Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
27/01/20	Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
27/01/20	Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
27/01/20	Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
24/01/20	Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
24/01/20	Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
24/01/20	Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
24/01/20	Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
23/01/20	Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
20/01/20	Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
17/01/20	Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
16/01/20	Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
16/01/20	Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
16/01/20	Veloxis Pharmaceuticals A/S : - Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants
15/01/20	Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
15/01/20	Veloxis Pharmaceuticals: Major Shareholder Notifications